| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2222.2004.01869.X |
| P698 | PubMed publication ID | 15005733 |
| P2093 | author name string | Akdis CA | |
| Akdis M | |||
| Akkoc T | |||
| Bahceciler NN | |||
| Barlan IB | |||
| Deniz G | |||
| Arikan C | |||
| P2860 | cites work | Atopic disorders: a vaccine around the corner? | Q34430856 |
| The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses | Q34468846 | ||
| Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma | Q39515670 | ||
| The expanding universe of T-cell subsets: Th1, Th2 and more. | Q41120396 | ||
| Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia | Q42971469 | ||
| Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae | Q47927509 | ||
| High-dose oral tolerance prevents antigen-induced eosinophil recruitment into the mouse airways | Q47992778 | ||
| Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. | Q49102034 | ||
| Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. | Q53551598 | ||
| Immunoprophylaxis of atopy: light at the end of the tunnel? | Q59310678 | ||
| Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response | Q73470671 | ||
| Effect of pre-immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin-sensitized newborn mice | Q78229032 | ||
| Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma | Q78966853 | ||
| Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults | Q87372920 | ||
| P433 | issue | 3 | |
| P921 | main subject | asthma | Q35869 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 398-405 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | Bacillus Calmette-Guérin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy | |
| P478 | volume | 34 |
| Q38055323 | Adjuvants for allergy vaccines |
| Q36150445 | Advances in allergen-specific immunotherapy |
| Q38113269 | Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications |
| Q47755374 | Antiallergic drugs and quality of life |
| Q80126897 | Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice |
| Q81196215 | Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production |
| Q36302823 | Emerging anti-inflammatory agents for allergic rhinitis |
| Q36228226 | IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses. |
| Q36515385 | Immunological mechanisms of sublingual immunotherapy |
| Q44290592 | Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites |
| Q81047272 | Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report |
| Q37453510 | Mechanisms of immune tolerance to allergens in children |
| Q37502904 | Mechanisms of sublingual immunotherapy |
| Q59791485 | Microphysiologic Human Tissue Constructs Reproduce Autologous Age-Specific BCG and HBV Primary Immunization |
| Q79222907 | Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: a double-blind, randomised study |
| Q37950136 | Specific immunotherapy in children: the evidence |
| Q36994648 | Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations |
| Q36583727 | Sublingual immunotherapy of allergic diseases |
| Q46961926 | Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production |
| Q36150810 | Targets in allergy-directed immunotherapy. |
| Q36404344 | Update on sublingual immunotherapy |
Search more.